Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Barry

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Vaccine|September 20, 2005
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig modelEileen M Barry, Jin Wang, Tao Wu, et al.
FEMS Immunology and Medical Microbiology|January 12, 2011
Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cellsMauricio J Farfán, Cecilia S Toro, Eileen M Barry, et al.
Plos Neglected Tropical Diseases|July 26, 2022
The role of CFA/I in adherence and toxin delivery by ETEC expressing multiple colonization factors in the human enteroid modelEmily M Smith, Christen L Grassel, Antonia Papadimas, et al.
Pathogens and Disease|August 12, 2016
Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit modelElizabeth Stinson, Le'Kneitah P Smith, Kelly Stefano Cole, et al.
Molecular Microbiology|May 11, 2012
Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposureChristina S Faherty, Julia C Redman, David A Rasko, et al.
Nature Reviews. Microbiology|June 15, 2007
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard roadMyron M Levine, Karen L Kotloff, Eileen M Barry, et al.
Vaccine|August 19, 2004
Recombinant Salmonella enterica serovar Typhi in a prime-boost strategyChristofer J Vindurampulle, Lilian F Cuberos, Eileen M Barry, et al.
Infection and Immunity|May 16, 2019
Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensisKatherine J O'Malley, Jennifer D Bowling, Eileen M Barry, et al.
Journal of Virology|January 9, 2009
Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunityMarcela F Pasetti, Karina Ramirez, Aldo Resendiz-Albor, et al.
Clinical and Vaccine Immunology : CVI|January 13, 2017
Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular ImmunityKatharina Richard, Barbara J Mann, Aiping Qin, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Vaccine|September 20, 2005
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig modelEileen M Barry, Jin Wang, Tao Wu, et al.
FEMS Immunology and Medical Microbiology|January 12, 2011
Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cellsMauricio J Farfán, Cecilia S Toro, Eileen M Barry, et al.
Plos Neglected Tropical Diseases|July 26, 2022
The role of CFA/I in adherence and toxin delivery by ETEC expressing multiple colonization factors in the human enteroid modelEmily M Smith, Christen L Grassel, Antonia Papadimas, et al.
Pathogens and Disease|August 12, 2016
Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit modelElizabeth Stinson, Le'Kneitah P Smith, Kelly Stefano Cole, et al.
Molecular Microbiology|May 11, 2012
Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposureChristina S Faherty, Julia C Redman, David A Rasko, et al.
Nature Reviews. Microbiology|June 15, 2007
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard roadMyron M Levine, Karen L Kotloff, Eileen M Barry, et al.
Vaccine|August 19, 2004
Recombinant Salmonella enterica serovar Typhi in a prime-boost strategyChristofer J Vindurampulle, Lilian F Cuberos, Eileen M Barry, et al.
Infection and Immunity|May 16, 2019
Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensisKatherine J O'Malley, Jennifer D Bowling, Eileen M Barry, et al.
Journal of Virology|January 9, 2009
Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunityMarcela F Pasetti, Karina Ramirez, Aldo Resendiz-Albor, et al.
Clinical and Vaccine Immunology : CVI|January 13, 2017
Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular ImmunityKatharina Richard, Barbara J Mann, Aiping Qin, et al.
Pageof 7